Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sander

Showing results (701-710 of 736) with videos related to

Pageof 74
Sort By:
Journal of Neuroinflammation|February 10, 2023
The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammationDirk Reinhold, Vadim Farztdinov, Yan Yan, et al.
Blood Advances|December 3, 2021
Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19Malgorzata Wygrecka, Anna Birnhuber, Benjamin Seeliger, et al.
Neurocritical Care|May 24, 2019
Common Data Elements for Unruptured Intracranial Aneurysms and Aneurysmal Subarachnoid Hemorrhage: Recommendations from the Working Group on Hospital Course and Acute Therapies-Proposal of a Multidisciplinary Research GroupAirton Leonardo de Oliveira Manoel, Mathieu van der Jagt, Sepideh Amin-Hanjani, et al.
Iscience|March 17, 2023
Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by OmicronJakob Kreye, S Momsen Reincke, Stefan Edelburg, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2025
Glycan microarray analysis of <i>Candida</i>-related antibodies in human and mice sera guides biomarker discovery and vaccine developmentEmelie E Reuber, Emer Hickey, Arnab Pradhan, et al.
Nature Nanotechnology|April 2, 2020
Phage capsid nanoparticles with defined ligand arrangement block influenza virus entryDaniel Lauster, Simon Klenk, Kai Ludwig, et al.
Journal of Neurosurgery|October 16, 2020
Continuous improvement in patient safety and quality in neurological surgery: the American Board of Neurological Surgery in the past, present, and futureMarjorie C Wang, Frederick A Boop, Douglas Kondziolka, et al.
Clinical Immunology (Orlando, Fla.)|September 22, 2020
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacyDimitrios C Mastellos, Bruno G P Pires da Silva, Benedito A L Fonseca, et al.
Infection|April 7, 2021
CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severityJan-Moritz Doehn, Christoph Tabeling, Robert Biesen, et al.
The Journal of Infectious Diseases|October 3, 2020
A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission SettingSarah M Hicks, Kai Pohl, Teresa Neeman, et al.
Pageof 74

Showing results (701-710 of 736) with videos related to

Sort By:
Pageof 74
Journal of Neuroinflammation|February 10, 2023
The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammationDirk Reinhold, Vadim Farztdinov, Yan Yan, et al.
Blood Advances|December 3, 2021
Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19Malgorzata Wygrecka, Anna Birnhuber, Benjamin Seeliger, et al.
Neurocritical Care|May 24, 2019
Common Data Elements for Unruptured Intracranial Aneurysms and Aneurysmal Subarachnoid Hemorrhage: Recommendations from the Working Group on Hospital Course and Acute Therapies-Proposal of a Multidisciplinary Research GroupAirton Leonardo de Oliveira Manoel, Mathieu van der Jagt, Sepideh Amin-Hanjani, et al.
Iscience|March 17, 2023
Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by OmicronJakob Kreye, S Momsen Reincke, Stefan Edelburg, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2025
Glycan microarray analysis of <i>Candida</i>-related antibodies in human and mice sera guides biomarker discovery and vaccine developmentEmelie E Reuber, Emer Hickey, Arnab Pradhan, et al.
Nature Nanotechnology|April 2, 2020
Phage capsid nanoparticles with defined ligand arrangement block influenza virus entryDaniel Lauster, Simon Klenk, Kai Ludwig, et al.
Journal of Neurosurgery|October 16, 2020
Continuous improvement in patient safety and quality in neurological surgery: the American Board of Neurological Surgery in the past, present, and futureMarjorie C Wang, Frederick A Boop, Douglas Kondziolka, et al.
Clinical Immunology (Orlando, Fla.)|September 22, 2020
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacyDimitrios C Mastellos, Bruno G P Pires da Silva, Benedito A L Fonseca, et al.
Infection|April 7, 2021
CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severityJan-Moritz Doehn, Christoph Tabeling, Robert Biesen, et al.
The Journal of Infectious Diseases|October 3, 2020
A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission SettingSarah M Hicks, Kai Pohl, Teresa Neeman, et al.
Pageof 74